Saturday 17 October 2026 Export PCRX’s income statement to Excel — free account

Pacira BioSciences, Inc.

PCRX Healthcare Drug Manufacturers Specialty & Generic

Pacira BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $726.4 million, up 3.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.24%, EPS grew 209.1%, free cash flow grew 502.5% and total debt fell 37.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

36.35 0.02 +0.06%

Follow PCRX

Alert me

Market cap: $1.5B
P/E: 104×
Fwd P/E: 33.7×
Dividend yield: —
F-score: 8/9
Altman Z: 2.02
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	2.90%	0.96%	0.71%	2.05%
Piotroski F-Score Full definition →		8	8	8	8
ROA Full definition →		1.52%	0.50%	0.37%	1.05%
ROIC Full definition →		3.03%	1.45%	1.84%	1.58%
Return on Tangible Assets Full definition →		3.55%	1.24%	0.95%	2.35%
Average Days of Receivables Full definition →		58.70	62.34	62.40	64.78
Free Cash Flow per Share Full definition →		2.82	3.07	3.28	4.55
Free Cash Flow Full definition →		124.20	136.66	132.71	179.52
Capital Expenditures Full definition →		(17.23)	(15.33)	(9.51)	(8.15)
Other line items
Cash ROIC Full definition →		9.20%	10.48%	10.84%	13.96%
Accounts Receivable Turnover Full definition →		6.64	6.12	6.38	6.05
Accounts Payable Turnover Full definition →		8.06	8.74	8.17	6.51
Inventory Turnover Full definition →		1.11	1.08	1.07	1.10
Average Days of Payables Full definition →		43.23	36.93	33.68	41.19
Days of Inventory on Hand Full definition →		385.39	372.59	361.43	316.59
Tax Rate Full definition →		(0.49)	(0.58)	(0.61)	(0.17)
Research and Development Expense of Revenue Full definition →		14.43%	16.15%	16.34%	16.36%
Selling, General and Administrative Expense of Revenue Full definition →		48.38%	50.76%	51.16%	50.81%
Share Based Compensation of Revenue Full definition →		7.85%	7.92%	7.69%	7.50%
Interest Coverage Full definition →		2.28	1.10	1.46	1.28
Operating CF/Net income Full definition →		6.60	21.61	27.68	12.82
Depreciation/Fixed assets Full definition →		0.59	0.63	0.66	0.64
Capex/Depreciation Full definition →		(0.20)	(0.17)	(0.11)	(0.10)
Revenue per Share Full definition →		16.28	16.30	18.16	18.91
Operating CF per Share Full definition →		3.21	3.41	3.51	4.76
Capex per Share Full definition →		(0.39)	(0.34)	(0.23)	(0.21)
Capex to Sales Full definition →		0.02	0.02	0.01	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly